Policy paper
UK Position Paper on Microbiome-Based Medicinal Products (MBMPs)
MHRA position paper, to help encourage the development and licensing of Microbiome-Based Medicinal Products (MBMPs) products in the UK.
Documents
Details
Microbiome-based medicinal products (MBMPs) represent an emerging class of therapeutics with the potential to address areas of significant unmet clinical need. The purpose of this position paper is to encourage the development and licensing of these products in the UK.
Updates to this page
Published 18 August 2026